📰 MRK Latest News
Last Updated: 2026.05.08 11:11:37
Recent Headlines
Merck Scientists Publish Landmark Paper on Novel Method for Large-Scale Biocatalytic Synthesis of Investigational Oral PCSK9 Inhibitor, Enlicitide Decanoate
BusinessWire
2026-05-08 11:11 AM
Merck Completes Acquisition of Terns Pharmaceuticals, Inc.
BusinessWire
2026-05-05 12:45 PM
Merck Completes Acquisition of Terns Pharmaceuticals, Inc.
BusinessWBusinessWire
2026-05-05 12:45 PM
Janux Therapeutics: Strong Buy As Pipeline Advances, Stock Trades Below Cash Value
SeekingAlpha
2026-05-04 11:33 PM
Merck: All The Focus On The Pipeline
SeekingAlpha
2026-05-03 8:10 AM
Merck's LOE Risks Mitigated - R&D And M&As Are Paying Off
SeekingAlpha
2026-05-02 1:49 PM
Merck & Co., Inc. (MRK) Q1 2026 Earnings Call Transcript
SeekingAlpha
2026-04-30 8:41 PM
Merck & Co., Inc. 2026 Q1 - Results - Earnings Call Presentation
SeekingAlpha
2026-04-30 1:30 PM
Merck Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin Manifestations
BusinessWire
2026-04-30 12:05 PM
Merck’s Playing with Heart Program Teams Up With Professional Baseball Clubs and Baseball Legends to Help Raise Awareness About LDL-C, Called “Bad” Cholesterol, and How It May Impact the Risk of Heart Attack or Stroke
BusinessWire
2026-04-28 10:45 AM
Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.
BusinessWire
2026-04-24 10:45 AM
Merck and Google Cloud Partner to Accelerate Agentic AI Enterprise Transformation
PRNewswire
2026-04-22 12:00 PM
FDA Approves Merck’s Once-Daily IDVYNSO™ (doravirine/islatravir)
BusinessWire
2026-04-21 6:11 PM
FDA Grants Priority Review for KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each with Padcev® (enfortumab vedotin-ejfv), for Cisplatin-Eligible Patients with Muscle-Invasive Bladder Cancer
BusinessWire
2026-04-20 10:48 AM
1Q26 Earnings: Where Street Estimates Are Too Low And Who Should Beat
SeekingAlpha
2026-04-15 4:54 PM
Revolution Medicines: PDAC Data Wows Wall Street - Jury's Out On Further Upside
SeekingAlpha
2026-04-13 4:35 PM
Ifinatamab Deruxtecan Granted Priority Review in the U.S. for Adult Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer who Experienced Disease Progression on or After Platinum-Based Chemotherapy
BusinessWire
2026-04-13 11:00 AM
Terns Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Terns Pharmaceuticals, Inc. - TERN
BusinessWire
2026-04-10 7:37 PM
Merck Begins Tender Offer to Acquire Terns Pharmaceuticals, Inc.
BusinessWire
2026-04-07 1:00 PM
🔮
Keep Stock Illuminati Free
100% independent. Zero paywalls. Zero subscriptions.
Your support keeps the data flowing.
Donate via PayPal
One-time or recurring — every dollar helps us add more data & features.